Abstract: . . .  tamoxifen. Cancer 1986; 57 : 2123-2126 21 Pino HC , Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC. Tamoxifen-associated steatohepatitis-Report of three cases. J Hepatol 1995; 23 : 95-97 22 Cai Q , Bensen M, Greene R, Kirchner J. Tamoxifen-induced tran- sient multifocal hepatic fatty infiltration. Am J Gastroenterol 2000; 95 : 277-279 Edited by Xu XQ and Zhu LH 1620 ISSN 1007-9327 CN 14-1219/ R World J Gastroenterol July 15, 2003 Volume 9 Number 7  . . .
. . .  cancer 1619 Page 3 3 Cheng CJ , You SL, Lin LH, Hsu WL, Yang YW. Cancer epidemi- ology and control in Taiwan: a brief review. Jpn J Clin Oncol 2002; 32 : S66-81 4 Boring CC , Squires BA, Tong T. Cancer statistics, 1991. CA Can- cer J Clin 1991; 41 : 19-36 5 Lanza FL , Nelson RS. Fatty metamorphosis of the liver in malig- nant neoplasia. Special reference to carcinoma of the breast. Can- cer 1968; 21 : 699-705 6 Foster KJ , Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver . Br J Radiol 1980; 53 : 440-442 . . .
. . .  Tamoxifen-induced fatty liver in patients with breast cancer . Lan- cet 1998; 351 : 725 18 Nguyen MC , Steward RB, Banerji MA. Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer . Int J Obesity 2001; 25 : 296-298 19 Lombardi B . Consideration on the pathogenesis of fatty liver . Lab Invest 1966; 15 : 1-20 20 Louis DB , Claude G, Cöme R. Severe lipemia induced by tamoxifen. Cancer 1986; 57 : 2123-2126 21 Pino HC , Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC. Tamoxifen-associated steatohepatitis-Report of three . . .
. . .  patients with breast cancer . Lan- cet 1998; 351 : 725 18 Nguyen MC , Steward RB, Banerji MA. Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer . Int J Obesity 2001; 25 : 296-298 19 Lombardi B . Consideration on the pathogenesis of fatty liver . Lab Invest 1966; 15 : 1-20 20 Louis DB , Claude G, Cöme R. Severe lipemia induced by tamoxifen. Cancer 1986; 57 : 2123-2126 21 Pino HC , Baptista A, Camilo ME, de Costa EB, Valente A, de Moura MC. Tamoxifen-associated steatohepatitis-Report of three cases. J Hepatol 1995; 23 . . .
. . .  J Natl Cancer Inst 1981; 67 : 785-789 16 Senie RT , Rosen PP, Rhodes P. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann In- tern Med 1992; 51 : 25-32 17 Ogawa Y , Murata Y, Nishioka A, Inomata T, Yoshida S. Tamoxifen-induced fatty liver in patients with breast cancer . Lan- cet 1998; 351 : 725 18 Nguyen MC , Steward RB, Banerji MA. Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer . Int J Obesity 2001; 25 : 296-298 19 Lombardi B . Consideration on the pathogenesis of fatty . . .
--2829,5,283,3102,14145